Dyslipidemia is a Risk Factor for the Incidence and Severity of Drug-Induced Liver Injury (DILI):
A Retrospective Population-Based Study in China - PMC Back to Top Skip to main content NIH …

Drug-induced liver injury (DILI) due to the use of prescription and non-prescription
medication by HIV-positive and HIV-negative patients is one of the main causes of acute …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver injury
worldwide. It covers a wide spectrum of hepatic disorders ranging from simple steatosis …

Background & Aims An international expert panel proposed a new definition for metabolic
dysfunction–associated fatty liver disease (MAFLD) as a name change from nonalcoholic …

As a result of the obesity epidemic, Nonalcoholic fatty liver disease (NAFLD) and its
complications have increased among millions of people. Consequently, a group of experts …

Type 2 diabetes mellitus (DM) is characterized by inability of faulty pancreatic β-cells to
secret a normal amount of insulin to maintain normal body consumption, and/or peripheral …

Obesity is characterized by the deposition of excessive body fat, and is caused by energy
imbalance, especially when consuming fat-rich diets. High fat diet (HFD)-associated obesity …

Introduction: Drug induced steatohepatitis (DISH), a form of drug induced liver injury (DILI) is
characterized by intracellular accumulation of lipids in hepatocytes and subsequent …

According to the World Health Organization, cardiovascular disease (CVD) remains the
leading cause of death worldwide, accounting for approximately 18 million deaths per year …

The newly proposed term “metabolic dysfunction-associated fatty liver disease”(MAFLD) is
replacing the old term “non-alcoholic fatty liver disease”(NAFLD) in many global regions …